The newest Alzheimer’s medicines can slow the disease, giving patients about ten extra months of independence. These drugs are called monoclonal antibodies and they lower a sticky protein called amyloid. However, they need big doses given by infusion once or twice a month.
Scientists now want a simpler, possibly stronger approach. Researchers at Washington University created a cell‑based therapy that works with just one injection. In mouse tests, the treatment stopped new amyloid plaques from forming and cut existing plaques in half.
Turning Brain Support Cells Into Clean‑Up Workers
The idea comes from cancer treatments called CAR‑T therapy. In that method, a patient’s T‑cells are edited to hunt cancer. Here, the team edited astrocytes – a common brain support cell – to carry a “CAR” tag that lets them find and eat amyloid proteins.
These engineered astrocytes act like tiny cleaners, seeking out the harmful plaques that make memory fade.
How Amyloid Plaques Harm the Brain
Alzheimer’s starts when amyloid‑beta builds up and sticks together, forming plaques. The plaques trigger damage that shrinks the brain and hurts thinking.
Normally, microglia, the brain’s own waste‑collectors, clear debris. In Alzheimer’s they become overwhelmed and can’t keep up.
Reprogramming Astrocytes to Remove Amyloid
Chen, a post‑doctoral researcher, used a harmless virus to insert a gene that makes the CAR tag on astrocytes. The tag lets the cells grab amyloid‑beta and swallow it. In mice that naturally develop plaques, the CAR‑astrocytes focused on cleaning the brain.
Testing the Therapy in Mice
Two groups of Alzheimer‑prone mice were used. One group received the virus before plaques appeared; the other got it after plaques were already present. After three months, the results were clear.
Young mice that got the early treatment showed no plaques at all, even though untreated mice normally have many by six months of age. Older mice that already had plaques saw the plaque load drop by about 50 percent.
Looking Ahead
The team has filed a patent for the CAR‑astrocyte method and plans to improve its accuracy. They also see potential for other brain diseases. By swapping the CAR tag for a target found on brain tumors, the same cells could be turned into tiny tumor hunters.